Intellectual Property India Publishes Patent Application for Anti-Cdh17 Antibody Or Antigen-Binding Fragment Thereof And Use Thereof

MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617084693 A) filed by Guangdong Fapon Biopharma Inc. on July 10, 2026, for Anti-Cdh17 Antibody Or Antigen-Binding Fragment Thereof And Use Thereof.

Inventors include Zhang, Yibo; Ding, Jiaojiao; Xiao, Haipeng; Wu, Xiaodong; Xiao, Liang; Ren, Baiguang; Lu, Di; and Huo, Yongting.

The application for the patent was published on September 04, 2026, under issue no. 36/2026.

Abstract: An anti-CDH17 antibody or an antigen-binding fragment thereof and the use thereof. The antibody can specifically bind to one or more extracellular domains in extracellular domains 1-7 of CDH17, has an ADCC activity, and can mediate cell endocytosis, thereby providing a ne...